BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 19051133)

  • 1. Pharmacogenomics of statin response.
    Mangravite LM; Wilke RA; Zhang J; Krauss RM
    Curr Opin Mol Ther; 2008 Dec; 10(6):555-61. PubMed ID: 19051133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of statin response.
    Mangravite LM; Krauss RM
    Curr Opin Lipidol; 2007 Aug; 18(4):409-14. PubMed ID: 17620857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics of statin responsiveness.
    Kajinami K; Akao H; Polisecki E; Schaefer EJ
    Am J Cardiol; 2005 Nov; 96(9A):65K-70K; discussion 34K-35K. PubMed ID: 16291017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics and pharmacogenomics of cholesterol-lowering therapy.
    Schmitz G; Schmitz-Madry A; Ugocsai P
    Curr Opin Lipidol; 2007 Apr; 18(2):164-73. PubMed ID: 17353665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics of lipid-lowering therapies.
    Hu M; Tomlinson B
    Pharmacogenomics; 2013 Jun; 14(8):981-95. PubMed ID: 23746191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic determinants of response to statins.
    Peters BJ; Klungel OH; de Boer A; Maitland-van der Zee AH
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):977-83. PubMed ID: 19673675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics: the outlook for genetic testing in statin therapy.
    Chasman DI; Ridker PM
    Nat Clin Pract Cardiovasc Med; 2005 Jan; 2(1):2-3. PubMed ID: 16265332
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacogenomics of cholesterol-lowering therapy.
    Schmitz G; Langmann T
    Vascul Pharmacol; 2006 Feb; 44(2):75-89. PubMed ID: 16337220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetic determinants of atorvastatin response.
    Rodrigues AC; Hirata MH; Hirata RD
    Curr Opin Mol Ther; 2007 Dec; 9(6):545-53. PubMed ID: 18041665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin and ezetimibe combination therapy in cardiovascular disease.
    Dembowski E; Davidson MH
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):183-8. PubMed ID: 19262375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of statin therapy in patients with preexisting liver disease.
    Onofrei MD; Butler KL; Fuke DC; Miller HB
    Pharmacotherapy; 2008 Apr; 28(4):522-9. PubMed ID: 18363535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins personalized.
    Superko HR; Momary KM; Li Y
    Med Clin North Am; 2012 Jan; 96(1):123-39. PubMed ID: 22391257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.
    Alagona P
    Am J Manag Care; 2009 Mar; 15(3 Suppl):S65-73. PubMed ID: 19355805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
    Pearson TA; Ballantyne CM; Veltri E; Shah A; Bird S; Lin J; Rosenberg E; Tershakovec AM
    Am J Cardiol; 2009 Feb; 103(3):369-74. PubMed ID: 19166691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitavastatin.
    Mukhtar RY; Reid J; Reckless JP
    Int J Clin Pract; 2005 Feb; 59(2):239-52. PubMed ID: 15854203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The power of statins: aggressive lipid lowering.
    Jones PH
    Postgrad Med; 2002 Oct; 112(4 Suppl):23-30. PubMed ID: 19667597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics of statins: achievements, whole-genome analyses and future perspectives.
    Postmus I; Verschuren JJ; de Craen AJ; Slagboom PE; Westendorp RG; Jukema JW; Trompet S
    Pharmacogenomics; 2012 May; 13(7):831-40. PubMed ID: 22594514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Statin pharmacokinetics].
    Hubácek JA; Adámková V; Zídková K; Ceska R; Zlatohlávek L; Stulc T; Horínek A; Vrablík M
    Vnitr Lek; 2008 Jan; 54(1):62-7. PubMed ID: 18390119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transporter pharmacogenetics and statin toxicity.
    Niemi M
    Clin Pharmacol Ther; 2010 Jan; 87(1):130-3. PubMed ID: 19890253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic predisposition to statin myopathy.
    Vladutiu GD
    Curr Opin Rheumatol; 2008 Nov; 20(6):648-55. PubMed ID: 18946323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.